Immune IQ is pioneering advancements in healthcare diagnostics through its innovative platform, Immune Reveal, which leverages artificial intelligence to decode the human immune system. This technology aims to transform disease detection by enabling early identification of various conditions, significantly improving treatment outcomes. Immune Reveal is designed to conduct comprehensive disease scans simultaneously, offering high accuracy and a low false-positive rate. Its user-friendly point-of-care analyzer is compact and cost-effective, making it accessible for healthcare professionals across diverse settings. The system's ability to detect diseases before symptoms arise positions it as a critical tool for proactive healthcare, shifting the focus from reactive treatment to early intervention.

The company is also focused on expanding its diagnostic capabilities through a unique test cartridge system and a robust AI-driven database. This infrastructure allows for rapid and efficient menu expansion, enabling the addition of numerous disease tests to the platform. Immune IQ's collaboration with esteemed partners, such as Honeywell and the Battelle Institute, enhances its technological capabilities, particularly in machine learning and integrated circuit development. The ongoing clinical studies and the potential for FDA approval further underscore the promise of Immune Reveal in revolutionizing global healthcare by making advanced diagnostics widely available, especially in underserved regions.

United States

Immune IQ has developed, in collaboration with Honeywell, the Immune Reveal platform. It reads disease information from a patient's immune system in 5 minutes to rapidly identify critical diseases, many not detectable today. Our powerful diagnostic approach has a much lower cost-per-test, a greater range of disease identification, and a shorter time to results than other cellular- and mRNA-based approaches.

Immune IQ's initial focus is sepsis, one of the world's greatest healthcare challenges.

Immune IQ

Company Details